Access courses anytime via our free app — available on iOS & Android:

ovarian follicle

What to Do When You Get Diagnosed with Low Ovarian Reserve

You were probably not expecting it.

Maybe you took a fertility test out of curiosity.
Maybe you were planning ahead and booked an egg-freezing consultation.
Maybe you’ve been trying for a year and this was the appointment where someone finally gave you a name for it.
However it happened, someone said a number out loud – your AMH, and the room changed shape.

And then, very often, one of two things happened. Either the appointment ended in eight minutes with no real explanation, or you were told, immediately and gently and devastatingly, to start thinking about donor eggs.

This guide is for the night after that appointment.

We are not doctors, and this is not medical advice. We are a support and education organisation, and what we can offer you is the thing most clinics don’t have time for: a map. What actually happens next, in what order, what your real options are, what questions to ask, and how the systems in the US and Europe differ in ways that will shape your choices more than most people realise.

Take a breath. You have more time and more options than you feel like you have right now.

 

First: what your number does and doesn’t mean

This is the single most important reframe, and almost nobody gets it in the appointment itself.

Low ovarian reserve, you may hear it called diminished ovarian reserve, or DOR, is an estimate of how many eggs you have left, not how good they are. AMH (anti-Müllerian hormone) is a blood marker that correlates with the size of your remaining egg pool, and it’s genuinely useful for one specific thing: predicting how your ovaries are likely to respond to stimulation drugs in an IVF cycle.

Here’s what it does not tell you, as fertility specialists repeatedly point out about what a low AMH result actually means:

  • It does not measure egg quality. Egg quality tracks much more closely with your age than with your AMH.
  • It does not tell you when you will reach menopause.
  • It is a weak predictor of natural conception, particularly if you’re under 35. Plenty of women with low AMH conceive without any intervention.
  • It is not a fixed number. AMH fluctuates from month to month, and it reads artificially low if you’re on hormonal birth control.

The sentence that gets passed around fertility communities more than any other, usually from one exhausted woman to another, is this: it only takes one egg. It’s not a platitude. It’s a correction to the maths your brain is doing at 2am.

One more thing worth knowing early: your regular periods were never proof that everything was fine. Researchers have specifically warned that women with significantly diminished reserve often continue to menstruate normally, which is exactly why this diagnosis blindsides so many people who felt perfectly healthy.

And you are far from alone in it. Prevalence rises steeply with age. In one large study of over 13,000 women, diminished reserve was found in around 6% of women aged 25–29, 11% at 30–34, and 29% at 35–39. If you’re in your twenties or early thirties and feel like a statistical freak, you are not one.

 

diagnosed with Low ovarian reserve

 

The first two weeks: what to feel, and what not to decide

The most useful advice we can give you about the first fortnight is almost entirely about restraint.

Feel it. What you’re experiencing is grief, for a version of the future you’d assumed was available. Women describe the moment as having their plans “ripped out from under them,” and they describe the isolation that follows as its own separate injury. That is a normal response to a real loss. You don’t need to be brave about it yet.

Don’t make irreversible decisions. Not in week one. Do not end a relationship, quit a job, empty a savings account, book a cycle abroad, or agree to a donor programme because you are frightened. Fear is a terrible project manager. Nothing about your biology will change materially in fourteen days, but your capacity to think clearly will change enormously.

Get out of the comparison spiral. You will be tempted to search for other women’s AMH numbers and rank yourself against them. Everyone does it. It helps no one. Someone else’s 0.4 and someone else’s 4.0 tell you nothing about your body, your ovaries, or your odds.

Do one practical thing. Request copies of all your results – the actual numbers, not the summary. AMH, antral follicle count (AFC), FSH, estradiol, and your age. You will need these for every conversation that follows, including a second opinion.

That’s it. That’s the whole first two weeks.

 

Your next appointment: the questions that change the conversation

Most women leave the diagnosis appointment realising, in the car park, all the things they meant to ask. Go into the next one with the list written down. You are allowed to read from a piece of paper.

About your results

  • What are my AMH, AFC, FSH and estradiol, and what do they mean together, not separately?
  • Is this low for my age, or typical for my age?
  • How much does this number vary if we retest?

About the clinician and the clinic

  • Do you specifically treat low ovarian reserve and low responders? Roughly how many patients like me do you see?
  • What proportion of your patients with a profile like mine use their own eggs?

About the plan

  • What stimulation protocols would you consider for me, and why that one? What are the alternatives, including mild or “mini” IVF, or priming protocols?
  • What response would you consider acceptable, and at what point would you cancel a cycle?
  • Realistically, by scenario, what are my chances with my own eggs?

About everything else

  • What are all my options, not just the one you’d choose for me?
  • What can I usefully do in the next three months while I decide?
  • What does each path cost, and what is covered where I live?

If a clinician can’t or won’t engage with the last question in that list “what are all my options”, that itself is information.

 

second opinion for low ovarian reserve diagnosis

 

When to get a second opinion (and why so many women wish they had, sooner)

This is where we want to be direct with you, because it’s the theme that comes up most in patient communities and the one where good advice makes the biggest difference.

A very large number of women are told, at or near the point of diagnosis, that donor eggs are their realistic option. Some are told this at 33. Some are told it before a single cycle has been attempted. The Human Fertilisation and Embryology Authority’s own patient stories include a woman being handed donor-egg consent forms moments after a failed cycle, and leaving “stunned, devastated, and by the time we’d left the car park, outraged.”

Donor eggs are a wonderful, legitimate, joyful route to a family. Thousands of families exist because of them. That is not the issue. The issue is being routed there before you have the information to choose it, by a clinic whose protocol menu may be narrower than the field’s.

Get a second opinion if:

  • You were pushed toward donor eggs without a discussion of alternatives.
  • You were offered exactly one protocol, with no explanation of why.
  • Your cycle was cancelled and the conclusion drawn was about you rather than about the protocol.
  • You felt rushed, dismissed, or spoken about rather than to.
  • You simply want one. That’s a sufficient reason.

Women who did this consistently report the same thing: the second or third clinic proposed something meaningfully different – a milder approach, an estrogen priming protocol, a “quality over quantity” strategy, or simply a willingness to try. Higher drug doses are not automatically better for low reserve, and clinics differ significantly in how they handle low responders. You are not shopping for someone who will tell you what you want to hear. You are shopping for someone who has actually seen a lot of patients like you.

 

Your options, laid out as a map, not a ladder

The most damaging way this is usually presented is as a staircase you descend when each step “fails.” It isn’t. It’s a set of parallel routes, and people move between them in both directions.

Trying naturally, with better information. Low AMH doesn’t close this door. Cycle tracking, timing, and addressing other factors (including your partner’s semen analysis, which is astonishingly often skipped) belong here.

Monitored or medicated cycles, and IUI. Lower cost, lower intensity, sometimes a reasonable first move depending on your full picture.

IVF with your own eggs. Including conventional stimulation, mild/mini-IVF, and “banking”, doing several retrievals to accumulate eggs or embryos before transferring. Banking is often the strategy that makes the most sense with low reserve, and it’s underexplained.

Egg or embryo freezing. Not just for people delaying, increasingly relevant because of this diagnosis. More on this below.

Donor eggs. A path chosen by a very large number of families, with its own emotional work, its own legal landscape, and its own timeline. It deserves to be chosen deliberately, not defaulted into.

Embryo donation. Less discussed, often significantly cheaper, and a real option.

Surrogacy, where it’s legal and relevant to your situation.

Adoption and fostering. Not a consolation prize and not “the easy alternative” — a distinct path with its own demands and its own profound rewards.

Choosing to stop. Deciding you’ve done enough, or building a full life without children, is a legitimate outcome and not a failure. Anyone who frames it otherwise is not helping you.

You do not have to know which of these is yours this month.

 

If you’re younger than you expected to be having this conversation

A meaningful share of women get this diagnosis in their late twenties or early thirties, often before they have a partner they’d choose to do this with, or before they feel remotely ready.

If that’s you, the pressure is real and the advice you’re getting (“don’t wait!”) is probably making things worse rather than clearer. A few honest framings:

Fertility preservation is insurance, not a guarantee. Not every frozen egg survives thawing, fertilises, or becomes a viable embryo, and with lower reserve you may need more than one retrieval to bank a meaningful number. An OB-GYN who froze her own eggs described it bluntly to NBC News as “an expensive lottery ticket”, warning that the marketing can be misleading. That doesn’t mean don’t do it. It means go in with accurate expectations rather than a brochure’s.

The urgency is real but it is not a fire alarm. Ovarian reserve declines gradually, not overnight. “Start the conversation earlier” is reasonable advice. “Decide everything this month” is not.

And you’re allowed to take a year to decide. Many women do exactly that, and describe the deciding as harder than the procedure.

 

Supplements, lifestyle, and the honest version

You are about to be handed a great deal of advice, much of it confident and some of it contradictory.

What the community actually does: CoQ10 (often as ubiquinol) and DHEA dominate the conversation, alongside vitamin D and omega-3s. The reference text almost everyone eventually reads is Rebecca Fett’s It Starts With the Egg. The theory people cite is the roughly 90-day window during which an egg matures before ovulation.

What’s honest to say: the evidence is mixed. Some studies are encouraging, others aren’t, and no supplement has been shown to reverse the biological aging of eggs or to regrow your reserve. Reported jumps in AMH are hard to interpret partly because AMH is naturally variable. One consultant’s line gets repeated in forums because it’s about right: at worst, it’s expensive urine.

Two cautions from women who’ve been through it. First, DHEA is not a casual supplement. It’s a hormone, it isn’t available over the counter in the UK and much of Europe, it’s inadvisable for some conditions including PCOS, and it should not be taken without your clinician. Second, more is not better. A commonly shared experience: a woman on an enormous stack of supplements had a cycle yielding zero eggs, stripped back to basics, and got nine. Overwhelm has its own cost.

Foundational lifestyle work – sleep, alcohol, smoking, movement, stress load, is worth doing because it’s worth doing, not because it will change your AMH.

 

supplements that help with low ovarian reserve

 

The money conversation deserves its own project plan

Treat this as a workstream, not an afterthought. It’s the factor most likely to determine how many attempts you get, and therefore your overall odds.

Work out, in writing: what one cycle costs including medication at your clinic; what a multi-cycle or banking plan would cost; what your insurance, national system, or employer actually covers; what a donor path would cost; and what your genuine ceiling is. Then decide, while calm, how many attempts you are prepared to fund before you re-evaluate. Making that decision in advance protects you from making it mid-crisis.

Which brings us to the part almost no clinic article covers.

 

The US and Europe are playing different games

Where you live changes your options more than most patients realise, and if you’re willing to travel, it changes them again.

The United States

Treatment is overwhelmingly private-pay. A single IVF cycle with your own eggs commonly runs in the mid-teens of thousands of dollars before medication, with medication adding several thousand more; donor-egg cycles typically land far higher again.

Coverage is a patchwork. RESOLVE, the National Infertility Association, tracks state-by-state insurance mandates. A substantial minority of states have fertility coverage laws, and a smaller subset of those actually include IVF. Even where mandates exist, they frequently exclude self-insured employers, which is how many large companies are structured. California’s SB 729, requiring large-group plans to cover multiple retrievals, took effect for plans issued or renewed from January 2026. A meaningful expansion, but still one state.

In practice, the most powerful access route in the US is your employer. A growing number of companies now offer fertility benefits that go well beyond standard insurance, often covering the kind of care that’s relevant when reserve is low, and sometimes covering donor eggs too. Most employees have no idea these exist. If you haven’t looked at your HR portal or benefits handbook, look this week, and ask directly rather than assuming the answer is no.

The gap, though, is rarely just financial. People are handed a benefit and have no idea how to use it, which questions to ask, which path suits them, what the decisions actually involve. 

That’s the part we work on: Family By Choice runs education programmes for employers, so that people planning a family get proper guidance long before they’re sitting in a consulting room trying to make a decision under pressure. If your workplace offers fertility support but no one has ever explained how any of it works, that’s something you can raise, and something we can help with.

Reach out to us to find out more about this programme.

 

Europe

Costs are dramatically lower, an own-egg cycle across much of Europe runs in the low thousands of euros, and public systems carry part of the load. But eligibility is where low ovarian reserve bites.

For example, England, IVF is funded through Integrated Care Boards, and provision varies so widely by area that it’s universally described as a postcode lottery: NICE recommends three cycles, but the overwhelming majority of ICBs fund fewer, and some fund none. Crucially for you, many ICBs apply an AMH threshold. Some NHS eligibility criteria exclude patients below a specified AMH level on the reasoning that response is likely to be poor. Read that carefully: in parts of the UK, this diagnosis can be the thing that disqualifies you from funded treatment. 

Scotland, Wales and Northern Ireland run more consistent (and generally more generous) provision. On the continent, systems typically fund treatment to a defined age cut-off. France, for example, funds to a woman’s 43rd birthday.

European clinical culture is more conservative: tighter limits on embryos transferred, more restrictions on add-ons and PGT in some countries, and, a genuine structural advantage, counselling is mandatory before donor treatment in several countries.

Donor law is where Europe splits hardest, and it matters enormously if donor eggs are on your map. Broadly, donation is anonymous in Spain, the Czech Republic and Greece, and identity-release in the UK, the Netherlands, Sweden, Germany, Portugal and Finland, with France having moved to identity-release for donations made from September 2022. Compensation rules differ too, from expenses-only to capped fixed amounts. The practical consequence: identity-release countries tend to have donor shortages and long waits, while Spain has the deepest donor pool in Europe and effectively no waiting list.

Crossing borders

This is why cross-border care is so common. Northern Europeans and Americans travel to Spain, the Czech Republic, Greece, Portugal and Cyprus for cost, for donor availability, for higher age limits, or for access as a single woman or same-sex couple, and the economics of treatment abroad can mean three cycles overseas cost less than one at home.

What it actually involves: a remote consultation, baseline monitoring at your local clinic, coordination of medication and records across two health systems, one or two trips for retrieval or transfer, and follow-up back home.

Before you book, sit with three things. Anonymity is irreversible. If you use an anonymous donor in Spain or the Czech Republic, your future child cannot later access that donor’s identity, and that is a decision made on their behalf. Confirm exactly what donor information the clinic will share with you and with your child. And check legal parentage in your home country before you travel, not after.

None of this is knowledge anyone is born with, and very little of it is explained anywhere before you need it. Employees end up doing this research alone, late at night, between meetings, in a language of ICBs and identity-release and age cut-offs that nobody ever taught them.

This is the gap Family By Choice fills for employers. Our education programmes help people understand their options, their local rules, and their real questions early, so the decisions get made with information rather than urgency. Increasingly, European employers are adding family-forming support alongside their existing benefits, and education is the part that makes the rest of it usable. If your workplace has never addressed any of this, it’s a fair thing to ask for.

 

Looking after your head, your relationship, and your boundaries

The medical part of this is a series of appointments. The rest of it runs constantly in the background, and it’s what most people are actually struggling with.

Get proper support, early. Not just a friend who means well. Fertility counsellors are a real specialism – in the UK, BICA maintains a directory of accredited fertility counsellors, and in the US the ASRM mental health professional group serves a similar function. Peer support groups matter too, and the single most repeated sentence in them is a version of “I felt less alone.”

Talk to your partner about the diagnosis and the decisions separately. Conflating them turns every conversation into a referendum. And notice if the emotional labour of researching, booking, scheduling and grieving has quietly become one person’s job.

Decide who you’re telling, and give yourself permission not to tell everyone. You’ll get “just relax and it’ll happen,” which places the blame squarely and unfairly on you, and “you can always just adopt,” which treats a complex path as a casual substitute. Prepared responses help: “That’s not how this works, but thank you for caring.” Or simply: “I’d rather not get into it.”

Handle work deliberately. Monitoring appointments cluster early in the morning and don’t reschedule around meetings. Decide in advance who needs to know and what you’ll say.

 

Talk to your partner about the low ovarian reserve diagnosis

 

Words that help, words that hurt

You will encounter clinical language that lands like a verdict. It’s worth knowing that this is being actively challenged inside medicine itself. Clinicians have written about how terms like “failed cycle” and “poor responder” wound patients, and “geriatric pregnancy” has been formally retired by professional bodies in favour of less loaded phrasing.

You’re allowed to reject the framing. Some swaps that patients find genuinely easier to live with:

Instead of Try
“Failed cycle” “The cycle didn’t result in a pregnancy”
“Poor responder” “My ovaries respond differently to stimulation”
“Ovarian failure” “Lower ovarian reserve”
“Giving up” “Choosing a different path”
“Last resort” “Another option”

And you’re allowed to say to a clinician, out loud: “Could you phrase that differently? That language is hard for me.” Most will.

 

What we’d want you to take from this

Your AMH is a data point about egg quantity. It is not a prognosis, not a deadline, and not a verdict on whether you get to be a parent.

You are entitled to a second opinion, a clinician who specialises in this, an explanation of every option rather than one, and language that doesn’t wound you. Where you live shapes what’s affordable and what’s legal, and that’s worth researching properly rather than assuming. And every path on the map, including the ones you haven’t considered yet, leads to families that are entirely real.

Give yourself the two weeks. Then start with the questions.

 

Ready to explore what comes next?

For many people, this journey eventually includes a conversation about egg donation, sometimes as the chosen path, sometimes simply as something to understand before deciding against it. Either way, it deserves more than a rushed ten minutes in a consulting room.

Our course The Gift of Life: Starting Your Journey with Egg Donation walks you through what donor conception actually involves – the practical process, the legal and emotional questions, how to think about anonymity and disclosure, and how to talk about it with your partner and, one day, your child.

You can take it at your own pace, from wherever you are, before you’ve decided anything at all.

Explore the course →

Reading this for your team rather than yourself? We also run family-forming education programmes for employers. Get in touch with our founders here.

 

This guide is provided for information and support. It is not medical advice, and it isn’t a substitute for a conversation with a qualified fertility specialist who knows your full history. Costs, insurance rules, funding criteria and donor legislation change frequently and vary by country and region. Please verify anything relevant to your situation before acting on it.

 

Related articles:

IVF Failed: What Are Your Real Next Options?

IVF Isn’t Working – How to Know When It’s Time to Consider Donor Eggs

How to Do IVF with Donor Eggs: A Complete Beginner’s Guide

 

Related courses:

Online Course: The Gift of Life: Starting Your Journey with Egg Donation

Explore Our Courses

Surrogacy Journey

From choosing a surrogate to legal preparation, our step-by-step surrogacy guidance covers it all.
Explore Courses

IVF & Fertility Journey

Master the latest evidence-based IVF strategies and fertility protocols with our expert-led courses.
Explore Courses

Egg, Sperm & Embryo Donation

Navigate donor selection, legal issues and parentage with confidence through our donation courses.
Explore Courses

Building LGBTQ+ Families

Inclusive, practical guidance for LGBTQ+ parents-by-choice, from IUI to surrogacy.
Explore Courses

Single Parent Journey

Dedicated support and resources for solo parents creating families on their own.
Explore Courses

Natural Fertility Support

Holistic courses on nutrition, mindset and fertility awareness to boost your natural chances.
Explore Courses

Mind and Body Preparations

Learn how to help yourself by switching to helpful mindset, while preparing your body for a specific journey so you stay healthy during the entire journey.
Explore Courses
our courses illustration showing woman in front of pc and camera
× Courses are available in English, Spanish, French, German, Croatian and Serbian.